Compare Deckers Outdoor Corp (DECK) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deckers Outdoor Corp vs GeneDx Holdings Corp — how do they compare? Deckers Outdoor Corp trades at $82.94 (market cap $11.24B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: Deckers Outdoor Corp is far larger — about 5.6× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Deckers Outdoor Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Deckers Outdoor Corp for 71 Days and GeneDx Holdings Corp for 19 Days on average.
| DECK | WGS | |
|---|---|---|
Market Cap | $11.24B | $2.02B |
Volume | 3,010,945 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $120.94 | $167.51 |
52-Week Low | $77.51 | $34.51 |
Typical Hold Time | 71 Days | 19 Days |
Enterprise Value | $10.11B | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deckers Outdoor (DECK) trades at $83.32, up 3.66% with strong momentum as technical indicators show bullish signals. The company demonstrates robust fundamentals with revenue growing from $3.2B in 2022 to $5.0B in 2025, net profit margin expanding to 19.37%, and attractive valuation metrics including P/E of 11.74. Recent earnings beats and strong HOKA/UGG brand performance support positive sentiment.
Outlook remains positive with 44.65% analyst buy ratings and $117.13 consensus price target suggesting 40% upside potential. Key risks include competitive pressures in footwear sector and potential consumer spending slowdown. The stock presents a compelling growth opportunity with strong cash flow generation and expanding margins.
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deckers Outdoor Corp
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
